# NHS England rules for AI scribes (ambient voice technology)

> NHS England's guidance and supplier registry for ambient voice technology: DTAC, DCB0129 and DCB0160 clinical safety standards, and where MHRA device rules apply.

Regulation · Regions: UK · By Precision research team (Precision) · Published 2026-11-15 · Reviewed 2026-11-15 · Source: https://precision.example/learn/uk-ambient-voice-technology-guidance

**TL;DR:** NHS England's guidance on AI-enabled ambient scribing expects suppliers to meet DTAC and the clinical safety standards DCB0129 (manufacturers) and DCB0160 (deployers), and runs a self-certified supplier registry. A reported July 2026 MHRA and NHS England package says tools that only transcribe, summarise or draft may sit outside device law.

## Key takeaways

- NHS England runs an ambient voice technology (AVT) supplier registry that is self-certified and requires the Digital Technology Assessment Criteria (DTAC).
- Clinical risk standards DCB0129 for manufacturers and DCB0160 for deployers apply, including a clinical safety case and hazard log.
- A reported MHRA and NHS England package dated 29 July 2026 says tools that only transcribe, summarise, structure or draft have no device status.
- Responsibility among platform providers, clinicians and health systems for errors is not definitively resolved.

## What does NHS England expect from AI scribes?

NHS England's guidance on AI-enabled ambient scribing sets expectations for suppliers and for organisations that deploy them. Suppliers are expected to meet the Digital Technology Assessment Criteria (DTAC), the clinical risk standard DCB0129, and, where a product is a medical device, MHRA registration. Deployers apply DCB0160.

## What is the supplier registry?

NHS England runs an ambient voice technology supplier registry. It is self-certified and is not a commercial framework. It launched in January 2026 with 19 suppliers and reportedly reached about 30.

| Requirement | Who it applies to | What it involves |
| --- | --- | --- |
| DTAC | Suppliers | Technology assessment criteria for digital health |
| DCB0129 | Manufacturers | Clinical safety case, hazard log, clinical safety officer |
| DCB0160 | Deployers | Local clinical risk management and a deployment safety case |
| MHRA registration | Suppliers whose product is a device | Device registration where applicable |

## Are scribes devices?

A reported MHRA and NHS England package dated 29 July 2026 says tools that only transcribe, summarise, structure or draft have no device status. We found this only in secondary sources, so treat it as a lead to check against MHRA's text.

## Who is liable when a scribe makes an error?

Responsibility among platform providers, clinicians and health systems is not definitively resolved in the UK, according to a July 2026 law-firm note. Clinicians who sign the record carry primary exposure in practice.

## What did we not verify?

We did not open the MHRA documents or the July 2026 package, and the registry size varies by source. Check NHS England's guidance and the MHRA directly.

## Frequently asked questions

### Are AI scribes regulated as medical devices in the UK?

A reported MHRA and NHS England package from 29 July 2026 says tools that only transcribe, summarise, structure or draft have no device status, but functions that go further may. This reading comes from secondary sources, so check the MHRA guidance for your product.

### What are DCB0129 and DCB0160?

They are NHS clinical risk management standards. DCB0129 applies to manufacturers of health IT systems and DCB0160 to organisations deploying them. Both involve a clinical safety case, a hazard log and a named clinical safety officer.

### What is the NHS England AVT supplier registry?

It is a national registry of ambient voice technology suppliers. It is self-certified, not a commercial framework, and requires DTAC and MHRA registration where a product is a device. It launched in January 2026 with 19 suppliers.

> Limits of this page: The 29 July 2026 package and the reading that transcription-only tools are outside device law come from secondary sources (law-firm and consultancy notes) and one law-firm note; we did not open the MHRA documents. The registry size we saw varies (19 suppliers at launch in January 2026, about 30 later).

## Where Precision fits

A clinical safety case for a scribe needs measured omission and hallucination rates with severity. Precision produces those on your own encounters. https://precision.example/solutions/ambient-scribes

## Sources

- Guidance on the use of AI-enabled ambient scribing products in health and care settings, NHS England: https://www.england.nhs.uk/long-read/guidance-on-the-use-of-ai-enabled-ambient-scribing-products-in-health-and-care-settings/
- Ambient scribing in the NHS: a compliance framework suppliers cannot ignore, Bird & Bird: https://biotalk.twobirds.com/post/102nfao/ambient-scribing-in-the-nhs-a-compliance-framework-suppliers-cannot-ignore
- MHRA AI Airlock sandbox phase 2 programme report, GOV.UK: https://gov.uk/government/publications/ai-airlock-sandbox-phase-2-programme-report
- AI liability and clinical negligence claims, Clyde & Co, 2026-07: https://www.clydeco.com/en/insights/2026/07/ai-liability-and-clinical-negligence-claims
